RX Roles Worth It?

rising soph ivy (brown/dmth/cornell). RX realistic if I start grinding now? The work has always interested me much more than regular IB. Is the extra studying really that much? I heard school matters much more for RX roles. At that point is the extra networking and studying worth the trade-off from just sticking regular coverage or industry groups if I'm going to be beat by HYP sweats, nepo, diversity (GWI)? Would appreciate any thoughts or advice.

Posted because of recent RX post about RX being sweaty

TLDR is it considerably harder enough to justify not spend time recruiting from lowish-mid ivy

9 Comments
 
Most Helpful

RX has been shifting away from only top target schools across the board (check out EVR/PJT/GUGG summer analyst classes), so def not impossible. Given ur at a low-mid ivy, the door is wide open for you.

Contrary to what ppl on this forum say, it is not that hard to study for RX, especially if you’re already studying for M&A (by which I mean know basic of acct. and fin.). Would recommend you check out the guide that is dedicated for RX (just google “RX interview guide”). It’s like $30-40 and gives u more or less every question you will be asked in ur RX interviews (besides the deals u have to read about). That guide + regular M&A studying takes 1 month max, so not rlly a lot for extra over gunning for a top coverage group.

No matter which group you go for, if it’s one that’s worth being in (top tier exits, interesting deal flow, top pay, smart seniors/colleagues), it’s going to be sweaty. If those things are not for you and you want to optimize for smth else (i.e. WLB), don’t try for RX groups or any other top groups.

 

If ur interested, then it’s worth it. If ur only in it for the exits, all this extra shit you have to learn is not worth the incremental exit ops

 

Spend the next few weeks of summer learning about credit and purchase the "Rx interview guide" like the other user mentioned. In my opinion, you should only pursue Rx if you have an interest in credit. It will make your life and studying 100x easier.

Obviously top Rx groups lend themselves to top PE buyout/credit/SS exits... as you move down the chain from top shops/brand names however, the best exits will be in credit roles. If you like credit you won't really care. But if you're gunning for M&A and PE it's probably easier to just do coverage or M&A banking to start.

You have nothing to lose at this point. Just purchase the guide and read up on the HL case study/other Rx content to see if it's your thing. Make a committed choice to recruiting for Rx by September assuming intern apps open before the New Year.

Wishing you the best. Feel free to PM

 

Was in the same position as you last year and attend one of those ivies. I landed a top rx group but gave it up for an m&a group. Happy to help tho since I went through the rx recruitment process so feel free to PM.

 

Adipisci minima facilis voluptatibus eligendi aut possimus in. At asperiores cupiditate vero voluptatum. Sunt ut voluptas sapiente vitae explicabo tempore alias. Sit aut aut et laborum. Sit est voluptatum mollitia reiciendis unde optio placeat. Quidem repellendus quaerat aut eligendi consequatur.

Rerum omnis ducimus est impedit minima. Quaerat ab qui exercitationem sed. Harum modi qui excepturi tenetur qui voluptatibus. Sint ullam et aut est qui. Modi ex ullam quibusdam velit qui.

Et optio quae et dolor voluptatem possimus nesciunt. Omnis sequi et velit enim. Eos quia sit est omnis. Ut officia et et magnam. Earum dolorem aspernatur pariatur aspernatur. Distinctio culpa ut maxime.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”